Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Financing Activities (2017 - 2025)

PAVmed has reported Cash from Financing Activities over the past 5 years, most recently at -$2000.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the TTM value through Dec 2025 reached $5.6 million, down 84.6%, while the annual FY2025 figure was $5.6 million, 82.13% down from the prior year.
  • Cash from Financing Activities for Q3 2025 was -$2000.0 at PAVmed, down from $2.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $60.1 million in Q4 2021 and troughed at -$2000.0 in Q3 2025.
  • A 5-year average of $11.7 million and a median of $2.8 million in 2025 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 99.87% in 2022 and later soared 7787.34% in 2023.
  • Year by year, Cash from Financing Activities stood at $60.1 million in 2021, then tumbled by 99.87% to $80000.0 in 2022, then skyrocketed by 6510.0% to $5.3 million in 2023, then crashed by 93.76% to $330000.0 in 2024, then tumbled by 100.61% to -$2000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for PAVM at -$2000.0 in Q3 2025, $2.5 million in Q2 2025, and $3.1 million in Q1 2025.